BPMC
Blueprint Medicines
BPMC
BPMC
Delisted
BPMC was delisted on the 17th of July, 2025.
261 hedge funds and large institutions have $5.69B invested in Blueprint Medicines in 2021 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 102 increasing their positions, 93 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
12% less capital invested
Capital invested by funds: $6.46B → $5.69B (-$770M)
24% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 46
51% less call options, than puts
Call options by funds: $8.55M | Put options by funds: $17.3M
Holders
261
Holding in Top 10
7
Calls
$8.55M
Puts
$17.3M
Top Buyers
| 1 | +$67.6M | |
| 2 | +$38.1M | |
| 3 | +$35.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$31.8M |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$29.8M |
Top Sellers
| 1 | -$49.8M | |
| 2 | -$21.6M | |
| 3 | -$18.1M | |
| 4 |
Morgan Stanley
New York
|
-$16.7M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$15.3M |